Literature DB >> 10849473

Epithelial damage and response.

S T Holgate1.   

Abstract

Epithelial damage is a characteristic feature of asthma. The epithelium is not merely a passive barrier but can generate a range of mediators that may play a role in the inflammatory and remodelling responses that occur in the lungs in asthma. For example, the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF), whose principal source is the epithelium, can prolong eosinophil survival while transforming growth factor is a potent profibrogenic cytokine. Deposition of collagen in the epithelial subbasement membrane is a characteristic feature of the remodelling response in asthma. This may be due to abnormal associations between myofibroblasts and epithelium, both of which are involved in early lung development (epithelial-mesenchymal trophic unit). In asthma, there may be a primary defect in the epithelium such that it responds abnormally to various stimuli and cannot undergo the normal repair response. Epidermal growth factor (EGF) appears to be a key factor in bronchial epithelial repair; it stimulates epithelial cell proliferation and migration. The 3v isoform of the adhesion molecule CD44 is overexpressed in damaged epithelium and seems to regulate the repair response by presenting EGF more efficiently to its receptor. Although EGF receptor expression is increased in asthma, it does not lead to an appropriate proliferative response and restitution of normal epithelium. Other factors such as transforming growth factor (TGF)beta which are generated by inflammatory cells and epithelium are also upregulated in asthma. An epithelial/fibroblast co-culture system has shown that following epithelial damage various growth factors are released from the underlying myofibroblasts and are responsible for the proliferative response. The TGFbeta family are most likely responsible for collagen production. In an in vitro study, an EGF receptor inhibitor slowed epithelial repair but enhanced TGFbeta production by the slowly repairing epithelial cells. In conclusion, the interaction between epithelial cells and myofibroblasts, i.e. reactivation of the epithelial-mesenchymal trophic unit appears to be central to the airway wall remodelling response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849473     DOI: 10.1046/j.1365-2222.2000.00095.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  49 in total

1.  Th2 cytokines IL-4 and IL-13 downregulate paxillin expression in bronchial airway epithelial cells.

Authors:  Gail Ramirez-Icaza; Kamal A Mohammed; Najmunnisa Nasreen; Robert D Van Horn; Joyce A Hardwick; Kerry L Sanders; Jun Tian; Carlos Ramirez-Icaza; Mary T Johnson; Veena B Antony
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

2.  Gangliosides of myelosupportive stroma cells are transferred to myeloid progenitors and are required for their survival and proliferation.

Authors:  Ana L Ziulkoski; Cláudia M B Andrade; Pilar M Crespo; Elisa Sisti; Vera M T Trindade; Jose L Daniotti; Fátima C R Guma; Radovan Borojevic
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

Review 3.  Airway epithelial cells: current concepts and challenges.

Authors:  Ronald G Crystal; Scott H Randell; John F Engelhardt; Judith Voynow; Mary E Sunday
Journal:  Proc Am Thorac Soc       Date:  2008-09-15

4.  Integrin-mediated transforming growth factor-beta activation regulates homeostasis of the pulmonary epithelial-mesenchymal trophic unit.

Authors:  Jun Araya; Stephanie Cambier; Alanna Morris; Walter Finkbeiner; Stephen L Nishimura
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

5.  Characterization of a novel model incorporating airway epithelial damage and related fibrosis to the pathogenesis of asthma.

Authors:  Simon G Royce; Krupesh P Patel; Chrishan S Samuel
Journal:  Lab Invest       Date:  2014-09-29       Impact factor: 5.662

Review 6.  Mechanisms how mucosal innate immunity affects progression of allergic airway disease.

Authors:  Allan R Brasier
Journal:  Expert Rev Respir Med       Date:  2019-02-13       Impact factor: 3.772

7.  ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma.

Authors:  Pei-Fen Chen; Ya-ling Luo; Wei Wang; Jiang-xin Wang; Wen-yan Lai; Si-ming Hu; Kai Fan Cheng; Yousef Al-Abed
Journal:  Mol Med       Date:  2010-05-14       Impact factor: 6.354

Review 8.  Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma.

Authors:  S S An; T R Bai; J H T Bates; J L Black; R H Brown; V Brusasco; P Chitano; L Deng; M Dowell; D H Eidelman; B Fabry; N J Fairbank; L E Ford; J J Fredberg; W T Gerthoffer; S H Gilbert; R Gosens; S J Gunst; A J Halayko; R H Ingram; C G Irvin; A L James; L J Janssen; G G King; D A Knight; A M Lauzon; O J Lakser; M S Ludwig; K R Lutchen; G N Maksym; J G Martin; T Mauad; B E McParland; S M Mijailovich; H W Mitchell; R W Mitchell; W Mitzner; T M Murphy; P D Paré; R Pellegrino; M J Sanderson; R R Schellenberg; C Y Seow; P S P Silveira; P G Smith; J Solway; N L Stephens; P J Sterk; A G Stewart; D D Tang; R S Tepper; T Tran; L Wang
Journal:  Eur Respir J       Date:  2007-05       Impact factor: 16.671

Review 9.  Epithelial restitution and wound healing in inflammatory bowel disease.

Authors:  Andreas Sturm; Axel U Dignass
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

10.  Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis.

Authors:  Hyun Sil Lee; Allen Myers; Jean Kim
Journal:  Am J Respir Crit Care Med       Date:  2009-09-17       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.